Neurological diseases, including multiple sclerosis (M.S.), often provoke changes in the functioning of the endothelial and epithelial brain barriers and give rise to disease-associated alterations of the cerebrospinal fluid (CSF) proteome. In the present study, pooled and ultrafiltered CSF of M.S. and non-M.S. patients were digested with trypsin and analyzed by off-line strong cation exchange chromatography (SCX) coupled to on-line reversed-phase LC-ESI-MS/MS. In an alternative approach, the trypsin-treated sub-proteomes were analyzed directly by LC-ESI-MS/MS and gas-phase fractionation in the mass spectrometer. Taken together, both proteomic approaches in combination with a three-step evaluation process including the search engines Sequest and Mascot, and the validation software Scaffold, resulted in the identification of 148 proteins. Sixty proteins were identified in CSF for the first time by mass spectrometry.
. CSF homeostasis depends directly on the epithelial blood-CSF barrier located at the choroid plexuses and the outer arachnoid membrane, and indirectly on the endothelial blood-brain barrier via the interstitial compartment of the brain 6, 7 . Neurological diseases, including M.S. often provoke changes in the functioning of these barriers 7, 8 and give rise to disease-associated alterations of the CSF proteome. Therefore, proteomic studies of CSF have been applied to study brain disorders such as Alzheimer [9] [10] [11] , Creutzfeld Jacob 12, 13 , schizophrenia 14 and M.S. 15, 16 . It is anticipated that neuroproteomics (and neurogenomics) will indicate paraclinical disease markers of diagnostic, prognostic or therapeutic value and will
give insight in brain disease initiation, propagation and recovery.
The complexity of the CSF proteome can be reduced by molecular fractionation 17 , a common practice in mass spectrometry-based proteomics. In this study, molecular partitioning and concomitant complexity reduction was achieved by combining ultrafiltration (exploiting molecular size), liquid chromatography (exploiting charge and/or polarity) and intensity-based precursor ion selection in the mass spectrometer with or without additional fractionation of the gas-phase in the ion trap mass spectrometer as described hereafter.
Ultrafiltration is mainly used for solute concentration, desalting and buffer exchange. The technique, however, was also successfully adapted to a variety of biological samples for the fractionation of proteins, enabling a more thorough analysis of a low-molecular weight protein fraction depleted from otherwise interfering molecules such as serum albumin, immunoglobulins, and other abundant, highmolecular weight proteins [18] [19] [20] [21] [22] . Centrifugal ultrafiltration of CSF served here the same purpose with focus on proteins in the 5 to 50 kDa MW range.
Traditionally, two-dimensional gel electrophoresis (2D-GE) has been the method of choice for the ultimate separation of CSF proteins. However, electrophoretic separation and subsequent staining of lower molecular weight proteins envisaged here, are yet not that obvious. Therefore, alternative separation technologies were considered for mining the CSF proteome 17, [23] [24] [25] [26] [27] [28] [29] [30] [31] . In the end and as a first approach, peptide-mapping by two-dimensional liquid chromatography (2D-LC) was chosen as a plausible alternative to 2D-GE, combining off-line capillary strong cation-exchange chromatography (SCX) and on-line microcapillary reversed-phase liquid chromatography coupled to electrospray ionisation tandem mass spectrometry (LC-ESI-MS/MS). In the mass spectrometer, and as a cyclic process, the three most intense precursor ions were selected automatically from an immediately preceding full scan for subsequent collision-induced fragmentation. In a second approach, ultrafiltered tryptic digests were analyzed directly by LC-ESI-MS/MS. Further reduction of sample complexity was now accomplished by gas-phase fractionation (GPF) 32, 33 in the mass spectrometer using a prescan mass width as small as 100 Th.
Repetitive injections of the same sample thus resulted in a detailed analysis of precursor ions in the 400-1400 Th mass range.
Using both proteomic approaches, in total 148 non-redundant proteins were identified in pooled CSF of relapsing-remitting M.S. patients and of a 'non-M.S.' control group. Special attention was given to the evaluation and validation of the underlying mass spectrometric data. This curative process was conducted in a semiautomatic way including the search engines Sequest and Mascot, and the statistical validation software Scaffold.
Experimental sections
CSF sampling and pooling. CSF samples were collected by means of lumbar puncture, centrifuged at 250 x g for 10 min and the aliquoted supernatant was stored at -80°C without the addition of protease in hibitors. CSF aliquots thus obtained from eight clinically diagnosed relapsing-remitting M.S. patients (all in clinical remission state) were thawed while on ice, pooled (8 times 600 µl; 343 µg protein/ml), mixed and finally divided in two equal sub-portions (M.S.A and M.S.B, 2.4 ml each) to allow for the exploration of different analytical procedures.
Detailed patient data are summarized in Table 1A . Because of bio-ethical restrictions associated with the collection of 'healthy' CSF in Belgium, six cancer patients were selected as a 'non-M.S.' control patients having normal clinical CSF parameters with no evidence for cerebral or leptomeningeal metastasis (Table 1B) . The 'non M.S.'
control pool was made up by combining 400 µl CSF aliquots from selected cancer patients (474 µg protein/ml).
Sample preparation. The three CSF pools were ultrafiltered using Centricon YM-50 columns (Millipore, Bedford, CA) with a nominal molecular weight cut-off (MWCO) of 50 kDa. The non-retained fraction from each pool was concentrated using Ultrafree columns (Millipore) with a nominal MWCO of 5 kDa. To the retentate (~30 µl), 70 µl denaturation solution (50mM Tris-HCl pH 8, 6M urea, 5mM dithiothreitol) was added and the sample was incubated at 56°C for 60 min followed by the addition of 300 µl alkylating solution (33mM iodoacetic amide in 50mM NH 4 HCO 3 ) and incubation at room temperature for 45 min. After ultrafiltration, the final 5 kDa retentate was subjected to trypsin digestion (2 µg, 37°C, overnight).
Digested protein samples were taken to dryness by in vacuo centrifugal evaporation and the respective residues were dissolved in 25 µl solution A (0.5% (v/v) acetic acid (HAc) in water). , except for the gradient slope which was halved to 0.46% ACN/min. (one for each of the six 10 µl sample aliquots analyzed): 400-600, 600-700, 700-800, 800-900, 900-1020 and 1020-1400 Th.
Two-dimensional liquid chromatography (2D-LC
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Database searching, validation and reporting. Peak lists in dta file format were generated from mass spectrometric raw data files using the CreateDTA tool available in Sequest v27 within BioWorks v3.0 (ThermoElectron). Subsequently, they were handled in a stepwise manner:
Step 1. Dta files derived from each SCX and GPF fraction were examined separately with the search engine Sequest using the database UniProt/Swiss-Prot protein knowledgebase release 42.0 (subset human; 12,088 sequences) or ipi-HUMAN (EBI release 3.02.0; 49,078 sequences). Sequest parameters were set as follows: Xcorr ≥ 1.8, ≥ 2.5 or ≥ 3.5 for singly, doubly or triply charged peptide ions; delta C n > 0.1; precursor and product ion mass tolerance ± 3 and ± 1 Da; enzyme:
trypsin; one missed cleavage allowed; static chemical modification: cysteinecarbamidomethylation; dynamic chemical modification: oxidation of methionine.
Sequest identifications were assembled in a DTASelect v1.9 report 34 , one for each study group. Only the dta files (and the corresponding result files in out file format) appearing in these reports, were retained for further evaluation in step 2 and 3, as described below (called hereafter 'reduced data set'). In addition, the proteins (and sibling peptides) identified in both study groups were compared and differentiated with the software Contrast 34 starting from the aforesaid DTASelect report files.
Contrast and DTASelect licenses were obtained from the Scripps Research Institute (La Jolla, CA).
Step 2. The reduced data set for each study group was merged and searched with Mascot (Matrix Science) against NCBInr (download date: March 25th 2005).
Search parameters were: taxonomy human, precursor and product ion mass tolerance ±3 and ±1 Da, enzyme: trypsin/P, one missed cleavage allowed. This operation resulted in two DAT files, one for each study group.
Step 3. Sequest DTA/OUT files (step 1) and Mascot DAT files (step 2) were cross-validated by Scaffold v1.0.07 (Proteome Software Inc.) for the non-M.S. and the M.S. group. The peptide identification probability was set to the maximum value of 95%. Protein identification probabilities for multiple peptide assignments were set to ≥ 98%. Because none of the single-peptide protein reached a protein identification probability higher than 93% irrespective the spectrum quality, this value was arbitrarily set to ≥ 91%.
To validate this three-step process just described, single-peptide protein identifications (so called 'one-hit wonders') were also examined with the de novo sequencing algorithm Lutefisk1900 (v. Two additional data analyses were performed according to the three-step evaluation process described above: a) to calculate the false-positive error rate, both reduced data sets were analyzed using the 'sequence-reversed' databases RV_ipi_human (step 1, Sequest search) and RV_NCBInr (step 2, Mascot search). These databases were generated from the database versions described above using an in-house developed Perl script and, b) to study the influence of fraction volume and fractionation modus on protein count the three proteomic experiments conducted in the M.S. group (SCX_1min_M.S.B, SCX_2min_M.S.A and GPF_M.S.A) were analyzed separately. The vast amount of information coming from the assembly of these SCX and GPF experiments is a general characteristic of gel-free mass spectrometric-based proteomics, also known as the bottom-up or the shotgun proteomic approach. In contrast to 2D-GE (where one spot contained only one or a few proteins), sibling tryptic peptides probably would be dispersed over several liquid fractions (SCX) or mass windows (GPF). In these experiments, the MS workload is related to the detail of fractionation (determined by fraction volume in SCX and by mass window width in GPF).
Results and Discussion
Gel
It is obvious that both the analytical performance of the instrument and the chromatographic process need to be as stable as possible. We monitored these parameters using an analytical internal standard (see experimental section). The coefficient of variation (CV) calculated for the retention time in each of both SCX_1min experiments (n = 55 each) was ≤ 2%. Peak height CV was 26% and 36% in the M.S. and non-M.S. group, respectively.
Database searching and validation. The number of confident protein identifications derived from the MS data is on the one hand dependent on the interplay between the search engine(s), the parameter settings and the searched protein database(s). On the other hand, the validity of the outcome of a proteomic experiment is dependent on the stringency of the validation process. In this study, a three-step process was followed for the evaluation of the data. Firstly, the data sets consisting of many thousands of dta files were examined with the search engine
Sequest. This operation resulted in a reduced data set freed from contaminants (e.g.
keratins) and consisting of 604 and 407 dta files in the M.S. and the non-M.S. patient group, respectively. In other words, only 0.65 % of the initial data set (155,714 dta files) was used in this study for protein identification. Secondly, the reduced data set was searched with Mascot. This engine returned a probabilistic score. Finally, the reports coming from both search engines were evaluated with Scaffold. This software probabilistically validates the peptide identifications done by Sequest and Mascot using PeptideProphet 37 and derives corresponding protein probabilities using ProteinProphet 38
. Peptides and assigned proteins meeting the preset criteria (as defined in experimental sections) were considered as confidently identified. The impact of the stepwise validation on peptide and protein counts for both groups and for each step is given in Table 2 .
It should be remarked that despite the applied three-step evaluation procedure, some of the peptide assignments still remain ambiguous. These include mass spectra which, upon visual inspection, displayed a high background noise and/or showed (multiple) unassigned ion peaks. Therefore, the single-peptide protein identifications were examined additionally with Lutefisk. This showed that 90% of the sequences returned by Sequest and Mascot matched one of the de novo sequences proposed by Lutefisk. In the other cases (indicated in Table 3 ), no quality de novo sequences could be derived (noisy spectra) or de novo sequences were not in agreement with those returned by both search engines.
Finally, the false-positive error rate for the reduced data set (1011 spectra) using the 'sequence-reversed' database and following the three-step evaluation process, was 0.9%.
Study outcome.
The assembly of the fractionation experiments performed on the three CSF pools followed by our stepwise validation strategy resulted in the identification of in total 148 proteins (Table 3) : 80 of which were found in common for both patient groups (Table 3a) , 24 proteins were shotgunned in the non-M.S. group (Table 3b ) and 44 only showed up in M.S. CSF (Table 3c ). Single-peptide protein identifications amounted to 45% in both the M.S. and non-M.S. group (Table 3 , Figure 3 ).
The non-identification of known CSF proteins in the non-M.S. groups including alpha-1-antitrypsin and serotransferrin (TRFE) does not necessarily imply that the peptides were not detected, but merely that they did not survive the stringent three step evaluation process. However, the high number of nonredundant peptides encountered in the M.S. group for TRFE on the one hand and the total lack of peptides reaching significance in the non-M.S. group remains unexplained. In two independent 1D electrophoresis experiments (of which one is presented here as supplemental material) TRFE was identified together with albumin as >50 kDa proteins that survived inexpectedly the 50 kDa ultrafiltration step, indicating an absolute MWCO being significantly higher than the specified nominal MWCO.
Subsequently, we should have encountered TRFE in both study groups. Van
Rensburg et al. 39 described a selective truncation of TRFE under conditions of inflammation which resulted in the appearance of a lower molecular weight protein designated as 'toxiferrin'. Since TRFE was detected here in M.S. patients only, conversion of TRFE to toxiferrin might have occurred. Therefore, M.S. and non-M.S.
CSF samples were analyzed with 1-D electrophoresis followed by western blotting using in-house raised monoclonal antibodies. Beside TRFE (77kDa) several lower molecular weight bands were immunodetected with no substantial difference in both groups. The reason why we did not detect peptides reaching significance in the non-M.S. group therefore remains obscure and might be related to the spin column itself, but certainly is unrelated to the mass spectrometrical process since analytical quality criteria (as judged from added internal standard) were always met in this study.
Indeed, 1D-GE analysis of a CSF (5-50 kDa) ultrafiltrate evidenced two weak gel bands that were identified by mass spectrometry as serotransferrin and serum albumin (supplemental material), To the best of our knowledge, 60 proteins were detected here for the first time in CSF by mass spectrometry (Table 4) , although some of these proteins were already indirectly evidenced by others in CSF (using alternative detection methods ) or in human brain studies (Table 3 and . From these 30 proteins five were also detected in our study: four proteins were present in both study groups (KLK6, CO4, PGCN and APOE) and had a comparable number of sibling peptides (see Table 3a ), while one other protein (PLMN) occurred in the non-M.S. group only (see Table 3b ).
PLMN, however, was shown to be downregulated in the elderly patient group 40 .
Based on these findings coming from a comparison of a limited set of proteins shown to be prone to age-related changes, we conclude that there is no evidence that the age difference between the M.S. and non-M.S. group had a substantial impact on the outcome of this qualitative study. . Although cystatin C has been studied extensively with respect to neurodegeneration [45] [46] [47] [48] [49] , little is known about the role of CYSA. Therefore, we performed a CYSA-specific ELISA (KRKA . Some of these proteins are known to form specific complexes 52 and could therefore be lost upon ultrafiltration as was confirmed here by 1D-GE analysis of the retentate (supplemental material). To deal with this drawback of ultrafiltration, future research will include the use of solvent conditions disrupting protein-protein interactions prior to ultrafiltration
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. Nevertheless, even under the conditions used in this study, the combination of ultrafiltration and liquid chromatography with or without GPF allowed for the mass spectrometric detection of a vast number of (less-abundant) yet unreported proteins in the < 50 kDa region. It should be stressed, however, that analytes such as cytokines and chemokines (molecular weight range ~8-30 kDa) were still undetected in our experimental setting (identification limit equivalent to ~3 femtomole bovine serum albumin; data not shown). These analytes were also missing from any other human CSF proteome study published so far.
Finally, the membranes used in ultrafiltration devices are characterized by a nominal MWCO. Their ability to retain molecules depends on the solute's molecular weight and size. Solutes with molecular weights close to the membrane cut-off are known to be only partially retained and flow-through may occur to some extent 50 , as illustrated in this study for serum albumin and TRFE (vide supra). In a total of 148 proteins identified in this study (Table 3) , 100 proteins (68%) had a precursor MW lower than 50 kDa, whereas 24 proteins (16%) were situated in the 50-90 kDa range.
Twenty-four proteins (16%) even had a MW of more than 90 kDa (Table 3 and 4) .
Their presence in the ultrafiltrate is probably due to (un)specific protein processing.
As a matter of fact, some truncated form(s) of reported > 90 kDa proteins were already annotated on 2D-gels by others in the lower (< 50 kDa) gel region, including perlecan, contactin 1, complement C3 and complement C4 53 , and neural-cadherin 54 .
Conclusion
Notwithstanding the unprecedented fractionating power of 2D-GE, ultrafiltration was here combined with chromatographic fractionation of CSF tryptic peptides with or without GPF. The applied ultrafiltration technique proved to be a valuable partitioning method that can be further optimized to increase specificity. The Pooled and ultrafiltered CSF of multiple sclerosis (M.S.) and non-M.S. patients were analyzed by 2D-LC-ESI-MS/MS and 1D-LC-ESI-MS/MS, the latter with gas-phase fractionation (GPF) in the iontrap.These proteomic approaches in combination with a three-step evaluation process resulted in the identification of in total 148 proteins, including 60 proteins evidenced here for the first time in CSF by mass spectrometry. 
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